NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.
This randomized controlled trial compares two AI-delivered psychotherapy approaches—psychodynamic and cognitive behavioral therapy—for treating social anxiety disorder. The study evaluates the efficacy of automated therapy systems in delivering evidence-based interventions.
A pilot randomized controlled trial examined whether metacognitive therapy (MCT), which targets anxiety-sustaining thought patterns, improves emotional distress tolerance and medication adherence in adults with generalized anxiety disorder. Patients receiving eight weekly MCT sessions showed significantly greater improvements in distress tolerance compared to a waitlist control group.
This study validates the GAD-7 anxiety scale in a Ukrainian sample of 1,101 adults during wartime, using confirmatory factor analysis and network analysis to examine how anxiety presents across age, gender, displacement status, and socioeconomic groups. Results show the scale maintains validity across most subgroups, though younger and older adults exhibit different central anxiety symptoms, with implications for tailored clinical interventions.
This experimental study transplanted fecal microbiota from patients with social anxiety disorder into antibiotic-treated mice and observed increased anxiety-like behaviors alongside altered gut microbial composition (enriched Bacteroidota, reduced butyrate producers) and metabolic changes. The findings provide mechanistic evidence for a gut-microbiota link in anxiety disorders, though results in animal models require validation in human studies before clinical application.
This case report describes outcomes in a patient with performance-only subtype social anxiety disorder treated with personalized repetitive transcranial magnetic stimulation (PrTMS) guided by spectral EEG analysis. Clinical improvements in social anxiety, avoidance, and mood were accompanied by changes in EEG spectral features (increased alpha, decreased delta power), suggesting PrTMS warrants further investigation as an adjunctive treatment, though large-scale randomized controlled trials are needed for validation.